Clik here to view.
Trends Update — Personalized Medicine: Clinical Data on Personalized Cancer...
A study presented at the American Association for Cancer Research meeting this week showed benefits to patients from using molecular profiling to customize chemotherapy regimens. The pilot study, with...
View ArticleClik here to view.
Pfizer and Ontario BIP Program Funding New $6.9 million “POP-CURE” Project...
Pfizer Global Research and Development is contributing $6 million and the Ontario government is contributing $900,000, through the Biopharmaceutical Investment Program (BIP), for a new project “to...
View ArticleClik here to view.
Trends Update —“Personalized Effectiveness”: Amgen Gets Prospective Data to...
A few weeks ago, when the FDA changed the labeling on anti-EGFR drugs, Amgen was pretty enthusiastic about “avoiding unnecessary treatments in patients [with a specific genetic marker] who are unlikely...
View ArticleClik here to view.
Québec’s $122 million New Biopharmaceutical Strategy Includes $30 million for...
The Province of Québec rolled out a new “biopharmaceutical strategy” Thursday that they say aims to provide “development support for biotech and biopharmaceutical firms.” The Roll-Out: The announcement...
View Article
